Contribution of Modifiable Midlife and Late-Life Vascular Risk Factors to Incident Dementia.

IF 20.4 1区 医学 Q1 CLINICAL NEUROLOGY
Jason R Smith, James Russell Pike, Rebecca F Gottesman, David S Knopman, Pamela L Lutsey, Priya Palta, B Gwen Windham, Elizabeth Selvin, Moyses Szklo, Karen J Bandeen-Roche, Josef Coresh, A Richey Sharrett, Alden L Gross, Jennifer A Deal
{"title":"Contribution of Modifiable Midlife and Late-Life Vascular Risk Factors to Incident Dementia.","authors":"Jason R Smith, James Russell Pike, Rebecca F Gottesman, David S Knopman, Pamela L Lutsey, Priya Palta, B Gwen Windham, Elizabeth Selvin, Moyses Szklo, Karen J Bandeen-Roche, Josef Coresh, A Richey Sharrett, Alden L Gross, Jennifer A Deal","doi":"10.1001/jamaneurol.2025.1495","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Midlife vascular risk factors are associated with an elevated risk of dementia. However, the total contribution of vascular risk factors in midlife and late life with incident dementia is uncertain.</p><p><strong>Objective: </strong>To quantify the proportion of incident dementia attributable to modifiable vascular risk factors measured in midlife and late life and to examine differences by apolipoprotein ε4 genotype, self-reported race, and sex.</p><p><strong>Design, setting, and participants: </strong>This was a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study using 33 years of follow-up (1987-2020). The setting included ARIC field centers (Jackson, Mississippi; Forsyth County, North Carolina; Minneapolis suburbs, Minnesota; Washington County, Maryland). Study baseline in Black and White participants with complete exposure and covariate data was set by age at risk factor measurement (45-54 years, 55-64 years, and 65-74 years). Data were analyzed from August 2023 to December 2024.</p><p><strong>Exposures: </strong>Hypertension (systolic blood pressure [BP] ≥130 mm Hg, diastolic BP ≥80 mm Hg, or use of medication for BP), diabetes (fasting glucose ≥126 mg/dL, nonfasting glucose ≥200 mg/dL, self-reported physician's diagnosis, or use of any diabetes medication), and current smoking (self-reported).</p><p><strong>Main outcomes and measures: </strong>Incident dementia. Population attributable fractions were estimated by age 80 years, and separately after 80 years, from having at least 1 vascular risk factor by age at risk factor measurement.</p><p><strong>Results: </strong>A total of 7731 participants were included in analysis of risk factors measured at age 45 to 54 years (4494 female [58%]; 2207 Black [29%]; 5524 White [71%]), 12 274 contributed to analysis of risk factors measured at age 55 to 64 years (6698 female [55%]; 2886 Black [24%]; 9388 White [76%]), and 6787 contributed to analysis of risk factors measured at age 65 to 74 years (3764 female [56%], 1375 Black [20%]; 5412 White [80%]). There were 801, 995, and 422 dementia cases by 80 years, respectively. The fraction of dementia by 80 years attributable to at least 1 vascular factor at age 45 to 54 years was 21.8% (95% CI, 14.3%-29.3%), at 55 to 64 years was 26.4% (95% CI, 19.1%-33.6%), and at 65 to 74 years was 44.0% (95% CI, 30.9%-57.2%). Attributable fractions for these factors were higher in apolipoprotein ε4 noncarriers at age 55 years and older (range, 33.3%-61.4%), Black individuals at age 45 years and older (range, 25.5%-52.9%), and female individuals at age 55 years and older (range, 29.2%-51.3%). Only 2% to 8% of dementia cases after 80 years were attributable to these factors.</p><p><strong>Conclusions and relevance: </strong>Results of this cohort study suggest that between 22% and 44% of incident dementia cases by 80 years in the ARIC study were attributed to midlife and late-life vascular risk factors. Assuming causal relationships, maintaining optimal vascular health across the life course could mitigate a sizeable proportion of dementia risk by 80 years.</p>","PeriodicalId":14677,"journal":{"name":"JAMA neurology","volume":" ","pages":"644-654"},"PeriodicalIF":20.4000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12131178/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamaneurol.2025.1495","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Importance: Midlife vascular risk factors are associated with an elevated risk of dementia. However, the total contribution of vascular risk factors in midlife and late life with incident dementia is uncertain.

Objective: To quantify the proportion of incident dementia attributable to modifiable vascular risk factors measured in midlife and late life and to examine differences by apolipoprotein ε4 genotype, self-reported race, and sex.

Design, setting, and participants: This was a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study using 33 years of follow-up (1987-2020). The setting included ARIC field centers (Jackson, Mississippi; Forsyth County, North Carolina; Minneapolis suburbs, Minnesota; Washington County, Maryland). Study baseline in Black and White participants with complete exposure and covariate data was set by age at risk factor measurement (45-54 years, 55-64 years, and 65-74 years). Data were analyzed from August 2023 to December 2024.

Exposures: Hypertension (systolic blood pressure [BP] ≥130 mm Hg, diastolic BP ≥80 mm Hg, or use of medication for BP), diabetes (fasting glucose ≥126 mg/dL, nonfasting glucose ≥200 mg/dL, self-reported physician's diagnosis, or use of any diabetes medication), and current smoking (self-reported).

Main outcomes and measures: Incident dementia. Population attributable fractions were estimated by age 80 years, and separately after 80 years, from having at least 1 vascular risk factor by age at risk factor measurement.

Results: A total of 7731 participants were included in analysis of risk factors measured at age 45 to 54 years (4494 female [58%]; 2207 Black [29%]; 5524 White [71%]), 12 274 contributed to analysis of risk factors measured at age 55 to 64 years (6698 female [55%]; 2886 Black [24%]; 9388 White [76%]), and 6787 contributed to analysis of risk factors measured at age 65 to 74 years (3764 female [56%], 1375 Black [20%]; 5412 White [80%]). There were 801, 995, and 422 dementia cases by 80 years, respectively. The fraction of dementia by 80 years attributable to at least 1 vascular factor at age 45 to 54 years was 21.8% (95% CI, 14.3%-29.3%), at 55 to 64 years was 26.4% (95% CI, 19.1%-33.6%), and at 65 to 74 years was 44.0% (95% CI, 30.9%-57.2%). Attributable fractions for these factors were higher in apolipoprotein ε4 noncarriers at age 55 years and older (range, 33.3%-61.4%), Black individuals at age 45 years and older (range, 25.5%-52.9%), and female individuals at age 55 years and older (range, 29.2%-51.3%). Only 2% to 8% of dementia cases after 80 years were attributable to these factors.

Conclusions and relevance: Results of this cohort study suggest that between 22% and 44% of incident dementia cases by 80 years in the ARIC study were attributed to midlife and late-life vascular risk factors. Assuming causal relationships, maintaining optimal vascular health across the life course could mitigate a sizeable proportion of dementia risk by 80 years.

中年和晚年可改变的血管危险因素对痴呆的影响。
重要性:中年血管危险因素与痴呆风险升高有关。然而,在中年和晚年发生痴呆的血管危险因素的总贡献是不确定的。目的:量化中年和晚年可改变血管危险因素引起的痴呆发生率,并考察载脂蛋白ε4基因型、自述种族和性别的差异。设计、环境和参与者:这是一项对社区动脉粥样硬化风险(ARIC)研究进行的前瞻性队列分析,随访33年(1987-2020)。设置包括ARIC现场中心(杰克逊,密西西比州;北卡罗莱纳州福赛斯县;明尼苏达州明尼阿波利斯郊区;马里兰州华盛顿县)。完全暴露和协变量数据的黑人和白人参与者的研究基线通过危险因素测量的年龄(45-54岁,55-64岁和65-74岁)设定。数据分析时间为2023年8月至2024年12月。暴露:高血压(收缩压[BP]≥130 mm Hg,舒张压≥80 mm Hg,或使用降压药物),糖尿病(空腹血糖≥126 mg/dL,非空腹血糖≥200 mg/dL,自我报告的医生诊断,或使用任何糖尿病药物),和目前吸烟(自我报告)。主要结局和指标:痴呆发生率。人群归因分数按年龄80岁估算,80岁后按年龄危险因素测量分别从至少有1个血管危险因素估算。结果:共有7731名参与者被纳入45岁至45岁的危险因素分析中(4494名女性[58%];2207黑色[29%];5524 White[71%]), 12 274参与了55 ~ 64岁人群的危险因素分析(6698名女性[55%];2886黑色[24%];9388例白人[76%]),6787例参与了65 ~ 74岁人群的危险因素分析(女性3764例[56%],黑人1375例[20%];[80%])。到80岁时,痴呆病例分别为801,995和422例。在45 - 54岁时,至少有一种血管因素导致的80岁痴呆比例为21.8% (95% CI, 14.3%-29.3%), 55 - 64岁时为26.4% (95% CI, 19.1%-33.6%), 65 - 74岁时为44.0% (95% CI, 30.9%-57.2%)。55岁及以上的载脂蛋白ε4非携带者(33.3% ~ 61.4%)、45岁及以上的黑人(25.5% ~ 52.9%)和55岁及以上的女性(29.2% ~ 51.3%)对这些因素的归因分数较高。80岁以后,只有2%到8%的痴呆病例可归因于这些因素。结论和相关性:该队列研究的结果表明,在ARIC研究中,到80岁时,22%至44%的痴呆病例归因于中年和晚年血管危险因素。假设存在因果关系,在整个生命过程中保持最佳的血管健康可以在80年内降低相当大比例的痴呆风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JAMA neurology
JAMA neurology CLINICAL NEUROLOGY-
CiteScore
41.90
自引率
1.70%
发文量
250
期刊介绍: JAMA Neurology is an international peer-reviewed journal for physicians caring for people with neurologic disorders and those interested in the structure and function of the normal and diseased nervous system. The Archives of Neurology & Psychiatry began publication in 1919 and, in 1959, became 2 separate journals: Archives of Neurology and Archives of General Psychiatry. In 2013, their names changed to JAMA Neurology and JAMA Psychiatry, respectively. JAMA Neurology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信